Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbiotics for Systemic Inflammation in CKD
NCT04769687Phase 2Unknown
- Sponsor
- CHU de Besançon
- Start
- Nov 2020
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by CHU de Besançon. Primary endpoint: Systemic Inflammation at 4 months. Status: unknown.
Beyond the preview
Go deeper on NCT04769687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769687.